List of Avi Biopharma, Inc. patents

Patents where

Current Assignee

Name

Avi Biopharma, Inc.

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7888012 Antisense composition and method for treating muscle atrophy	Patent 7888012 was granted and assigned to Avi Biopharma, Inc. on February, 2011 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7888012	February 15, 2011
‌ US Patent 7943762 Oligonucleotide analogs having cationic intersubunit linkages	Patent 7943762 was granted and assigned to Avi Biopharma, Inc. on May, 2011 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7943762	May 17, 2011
‌ US Patent 7507196 Antisense antiviral compounds and methods for treating a filovirus infection	Patent 7507196 was granted and assigned to Avi Biopharma, Inc. on March, 2009 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7507196	March 24, 2009
‌ US Patent 8067569 Splice-region antisense composition and method	Patent 8067569 was granted and assigned to Avi Biopharma, Inc. on November, 2011 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	8067569	November 29, 2011
‌ US Patent 8436163 Splice-region antisense composition and method	Patent 8436163 was granted and assigned to Avi Biopharma, Inc. on May, 2013 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	8436163	May 7, 2013
‌ US Patent 7468418 Compositions for enhancing transport of molecules into cells	Patent 7468418 was granted and assigned to Avi Biopharma, Inc. on December, 2008 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7468418	December 23, 2008
‌ US Patent 7094765 Antisense restenosis composition and method	Patent 7094765 was granted and assigned to Avi Biopharma, Inc. on August, 2006 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7094765	August 22, 2006
‌ US Patent 7238675 Antisense antibacterial method and composition	Patent 7238675 was granted and assigned to Avi Biopharma, Inc. on July, 2007 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7238675	July 3, 2007
‌ US Patent 6841542 Transforming growth factor beta (TGF-β) blocking agent-treated stem cell composition and method	Patent 6841542 was granted and assigned to Avi Biopharma, Inc. on January, 2005 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	6841542	January 11, 2005
‌ US Patent 7524829 Antisense antiviral compounds and methods for treating a filovirus infection	Patent 7524829 was granted and assigned to Avi Biopharma, Inc. on April, 2009 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7524829	April 28, 2009
‌ US Patent 8076476 Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits	Patent 8076476 was granted and assigned to Avi Biopharma, Inc. on December, 2011 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	8076476	December 13, 2011
‌ US Patent 9572899 Compositions for enhancing transport of molecules into cells	Patent 9572899 was granted and assigned to Avi Biopharma, Inc. on February, 2017 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	9572899	February 21, 2017
‌ US Patent 8067571 Antibacterial antisense oligonucleotide and method	Patent 8067571 was granted and assigned to Avi Biopharma, Inc. on November, 2011 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	8067571	November 29, 2011
‌ US Patent 7884194 Soluble HER2 and HER3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of disease	Patent 7884194 was granted and assigned to Avi Biopharma, Inc. on February, 2011 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7884194	February 8, 2011
‌ US Patent 8053420 Peptide conjugated, inosine-substituted antisense oligomer compound and method	Patent 8053420 was granted and assigned to Avi Biopharma, Inc. on November, 2011 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	8053420	November 8, 2011
‌ US Patent 7754238 Delivery of microparticle-conjugated drugs for inhibition of stenosis	Patent 7754238 was granted and assigned to Avi Biopharma, Inc. on July, 2010 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7754238	July 13, 2010
‌ US Patent 8084433 Antisense antiviral compound and method for treating ssRNA viral infection	Patent 8084433 was granted and assigned to Avi Biopharma, Inc. on December, 2011 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	8084433	December 27, 2011
‌ US Patent 7402574 Antisense composition and method for treating cancer	Patent 7402574 was granted and assigned to Avi Biopharma, Inc. on July, 2008 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7402574	July 22, 2008
‌ US Patent 7807801 Oligonucleotide analog and method for treating flavivirus infections	Patent 7807801 was granted and assigned to Avi Biopharma, Inc. on October, 2010 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7807801	October 5, 2010
‌ US Patent 7855283 Antisense antiviral compound and method for treating arenavirus infection	Patent 7855283 was granted and assigned to Avi Biopharma, Inc. on December, 2010 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7855283	December 21, 2010
‌ US Patent 7625873 Antisense antibacterial method and compound	Patent 7625873 was granted and assigned to Avi Biopharma, Inc. on December, 2009 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7625873	December 1, 2009
‌ US Patent 7115583 Microbubble compositions and methods for oligonucleotide delivery	Patent 7115583 was granted and assigned to Avi Biopharma, Inc. on October, 2006 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7115583	October 3, 2006
‌ US Patent 8415313 Antisense oligomers and methods for inducing immune tolerance and immunosuppression	Patent 8415313 was granted and assigned to Avi Biopharma, Inc. on April, 2013 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	8415313	April 9, 2013
‌ US Patent 7790694 Antisense antibacterial method and compound	Patent 7790694 was granted and assigned to Avi Biopharma, Inc. on September, 2010 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7790694	September 7, 2010
‌ US Patent 7264925 Method for analysis of oligonucleotide analogs	Patent 7264925 was granted and assigned to Avi Biopharma, Inc. on September, 2007 by the United States Patent and Trademark Office.	Avi Biopharma, Inc.	United States Patent and Trademark Office	7264925	September 4, 2007

Results per page:

35 results

0 selected

35 results

0 selected